Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 353 | 2024 | 6773 | 22.210 |
Why?
|
Aspirin | 86 | 2024 | 3282 | 11.290 |
Why?
|
Diverticulitis | 13 | 2023 | 171 | 6.680 |
Why?
|
Adenoma | 49 | 2023 | 2174 | 5.170 |
Why?
|
Colitis, Ulcerative | 36 | 2023 | 1912 | 5.170 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 48 | 2022 | 2282 | 5.090 |
Why?
|
Diet | 77 | 2023 | 7939 | 4.820 |
Why?
|
Crohn Disease | 34 | 2023 | 2303 | 4.550 |
Why?
|
Dietary Fiber | 21 | 2023 | 760 | 4.500 |
Why?
|
Prospective Studies | 271 | 2024 | 53288 | 3.660 |
Why?
|
Anticarcinogenic Agents | 10 | 2018 | 253 | 3.510 |
Why?
|
Carcinoma, Hepatocellular | 26 | 2024 | 2214 | 3.170 |
Why?
|
Risk Factors | 297 | 2024 | 72290 | 3.110 |
Why?
|
Colonic Polyps | 21 | 2023 | 542 | 3.080 |
Why?
|
Microsatellite Instability | 42 | 2024 | 684 | 3.050 |
Why?
|
Colonic Neoplasms | 35 | 2023 | 2541 | 3.010 |
Why?
|
Liver Neoplasms | 31 | 2024 | 4253 | 2.810 |
Why?
|
Proton Pump Inhibitors | 8 | 2023 | 526 | 2.670 |
Why?
|
Vitamin D | 26 | 2023 | 3223 | 2.650 |
Why?
|
Follow-Up Studies | 155 | 2024 | 39050 | 2.570 |
Why?
|
Gastroesophageal Reflux | 6 | 2023 | 782 | 2.510 |
Why?
|
Colonoscopy | 24 | 2023 | 1367 | 2.420 |
Why?
|
Diverticulitis, Colonic | 5 | 2021 | 128 | 2.410 |
Why?
|
Sigmoidoscopy | 6 | 2022 | 156 | 2.400 |
Why?
|
Middle Aged | 396 | 2024 | 213383 | 2.330 |
Why?
|
Proportional Hazards Models | 87 | 2023 | 12354 | 2.270 |
Why?
|
Cyclooxygenase 2 | 15 | 2020 | 611 | 2.250 |
Why?
|
Nurses | 34 | 2023 | 2461 | 2.200 |
Why?
|
Humans | 696 | 2024 | 744343 | 2.190 |
Why?
|
Feeding Behavior | 26 | 2021 | 3188 | 2.170 |
Why?
|
Incidence | 102 | 2023 | 20947 | 2.160 |
Why?
|
Vegetables | 12 | 2021 | 1182 | 2.100 |
Why?
|
Polymorphism, Single Nucleotide | 97 | 2023 | 15519 | 2.100 |
Why?
|
Genetic Predisposition to Disease | 84 | 2023 | 17446 | 2.060 |
Why?
|
Aged | 316 | 2024 | 163280 | 2.060 |
Why?
|
Female | 472 | 2024 | 380194 | 1.970 |
Why?
|
Inflammatory Bowel Diseases | 18 | 2023 | 2425 | 1.790 |
Why?
|
Case-Control Studies | 106 | 2023 | 21746 | 1.780 |
Why?
|
Adult | 298 | 2024 | 214055 | 1.760 |
Why?
|
Sulfur | 3 | 2021 | 166 | 1.720 |
Why?
|
Fruit | 11 | 2021 | 1142 | 1.710 |
Why?
|
Early Detection of Cancer | 15 | 2023 | 3086 | 1.660 |
Why?
|
Male | 381 | 2024 | 350118 | 1.650 |
Why?
|
Sulfur-Reducing Bacteria | 2 | 2021 | 16 | 1.630 |
Why?
|
Fatty Acids, Omega-3 | 9 | 2022 | 1344 | 1.620 |
Why?
|
Chemoprevention | 8 | 2022 | 319 | 1.580 |
Why?
|
Feces | 11 | 2023 | 1401 | 1.580 |
Why?
|
Cyclooxygenase 2 Inhibitors | 11 | 2017 | 320 | 1.570 |
Why?
|
Proto-Oncogene Proteins B-raf | 33 | 2023 | 2043 | 1.520 |
Why?
|
Obesity | 40 | 2023 | 12745 | 1.500 |
Why?
|
United States | 142 | 2023 | 69872 | 1.490 |
Why?
|
Risk Assessment | 83 | 2023 | 23338 | 1.480 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 15 | 2022 | 1038 | 1.420 |
Why?
|
CpG Islands | 25 | 2023 | 1172 | 1.410 |
Why?
|
Body Mass Index | 62 | 2023 | 12720 | 1.390 |
Why?
|
Vitamins | 10 | 2023 | 1622 | 1.380 |
Why?
|
Smoking | 36 | 2023 | 8987 | 1.370 |
Why?
|
Defecation | 4 | 2023 | 188 | 1.370 |
Why?
|
Stomach Neoplasms | 4 | 2022 | 1333 | 1.370 |
Why?
|
Life Style | 26 | 2022 | 3835 | 1.350 |
Why?
|
Cohort Studies | 93 | 2023 | 40561 | 1.340 |
Why?
|
Fecal Incontinence | 4 | 2022 | 239 | 1.320 |
Why?
|
Gastrointestinal Hemorrhage | 7 | 2020 | 1130 | 1.310 |
Why?
|
Anti-Inflammatory Agents | 6 | 2024 | 1790 | 1.310 |
Why?
|
Meat | 7 | 2024 | 592 | 1.290 |
Why?
|
Multivariate Analysis | 46 | 2020 | 12245 | 1.290 |
Why?
|
Genome-Wide Association Study | 62 | 2023 | 12261 | 1.270 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 5 | 2023 | 379 | 1.260 |
Why?
|
Adiponectin | 9 | 2019 | 1100 | 1.260 |
Why?
|
Fusobacterium nucleatum | 10 | 2021 | 162 | 1.250 |
Why?
|
Contraceptives, Oral | 6 | 2018 | 564 | 1.240 |
Why?
|
Adenomatous Polyps | 4 | 2021 | 107 | 1.240 |
Why?
|
Gastroenterology | 4 | 2023 | 536 | 1.220 |
Why?
|
Mendelian Randomization Analysis | 18 | 2023 | 967 | 1.200 |
Why?
|
Glutens | 5 | 2021 | 230 | 1.150 |
Why?
|
Adiposity | 11 | 2021 | 1807 | 1.090 |
Why?
|
Estrogen Replacement Therapy | 8 | 2019 | 1203 | 1.090 |
Why?
|
Smad7 Protein | 3 | 2021 | 41 | 1.050 |
Why?
|
Seafood | 4 | 2019 | 384 | 1.040 |
Why?
|
Growth Differentiation Factor 15 | 3 | 2015 | 176 | 1.030 |
Why?
|
Primary Prevention | 7 | 2022 | 1167 | 1.030 |
Why?
|
C-Reactive Protein | 13 | 2022 | 3778 | 1.020 |
Why?
|
Anti-Bacterial Agents | 10 | 2022 | 7181 | 1.020 |
Why?
|
Genetic Loci | 16 | 2023 | 2575 | 1.020 |
Why?
|
Diet Surveys | 12 | 2021 | 1173 | 1.010 |
Why?
|
Digestive System Neoplasms | 2 | 2021 | 87 | 0.990 |
Why?
|
Dietary Supplements | 17 | 2021 | 3297 | 0.970 |
Why?
|
Precancerous Conditions | 6 | 2021 | 975 | 0.950 |
Why?
|
Postmenopause | 10 | 2021 | 2461 | 0.910 |
Why?
|
Health Personnel | 19 | 2024 | 3218 | 0.910 |
Why?
|
Personnel Selection | 2 | 2015 | 189 | 0.900 |
Why?
|
Prognosis | 71 | 2023 | 29063 | 0.900 |
Why?
|
Alcohol Drinking | 17 | 2022 | 3966 | 0.900 |
Why?
|
Vitamin D Deficiency | 7 | 2022 | 1343 | 0.900 |
Why?
|
Neoplasms | 27 | 2024 | 21683 | 0.890 |
Why?
|
Health Surveys | 23 | 2021 | 4037 | 0.880 |
Why?
|
Reproductive History | 3 | 2018 | 209 | 0.880 |
Why?
|
Adenocarcinoma | 12 | 2022 | 6364 | 0.870 |
Why?
|
Risk Reduction Behavior | 6 | 2020 | 1125 | 0.870 |
Why?
|
Sex Hormone-Binding Globulin | 7 | 2022 | 548 | 0.860 |
Why?
|
Multiple Sclerosis | 18 | 2023 | 3079 | 0.860 |
Why?
|
Cholecalciferol | 4 | 2015 | 537 | 0.850 |
Why?
|
Platelet Aggregation Inhibitors | 8 | 2020 | 3068 | 0.850 |
Why?
|
Bacteria | 6 | 2023 | 2114 | 0.840 |
Why?
|
Rectal Neoplasms | 11 | 2022 | 1206 | 0.840 |
Why?
|
Carcinoma | 10 | 2023 | 2375 | 0.840 |
Why?
|
Inflammation | 20 | 2023 | 10638 | 0.820 |
Why?
|
Hyperinsulinism | 5 | 2023 | 415 | 0.820 |
Why?
|
Cyclooxygenase Inhibitors | 5 | 2013 | 371 | 0.820 |
Why?
|
Iron, Dietary | 2 | 2017 | 141 | 0.810 |
Why?
|
DNA Methylation | 32 | 2023 | 4286 | 0.800 |
Why?
|
Sulfur Compounds | 1 | 2021 | 31 | 0.800 |
Why?
|
Odds Ratio | 42 | 2021 | 9849 | 0.800 |
Why?
|
Diabetes Mellitus, Type 2 | 18 | 2023 | 11725 | 0.790 |
Why?
|
Inflammation Mediators | 6 | 2021 | 1889 | 0.790 |
Why?
|
Polypharmacy | 2 | 2021 | 294 | 0.750 |
Why?
|
Cardiovascular Diseases | 19 | 2023 | 15165 | 0.750 |
Why?
|
Exercise | 15 | 2023 | 5615 | 0.750 |
Why?
|
Dinoprostone | 2 | 2020 | 600 | 0.750 |
Why?
|
Arylamine N-Acetyltransferase | 2 | 2014 | 86 | 0.750 |
Why?
|
Gallstones | 5 | 2022 | 286 | 0.750 |
Why?
|
Irritable Bowel Syndrome | 2 | 2023 | 445 | 0.740 |
Why?
|
Cognition | 5 | 2023 | 6770 | 0.730 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 21 | 2023 | 1692 | 0.730 |
Why?
|
Berberine | 1 | 2020 | 25 | 0.710 |
Why?
|
Colitis, Microscopic | 4 | 2022 | 77 | 0.700 |
Why?
|
Tumor Microenvironment | 17 | 2022 | 3586 | 0.700 |
Why?
|
Risk | 34 | 2023 | 9687 | 0.690 |
Why?
|
Vitamin D-Binding Protein | 2 | 2020 | 129 | 0.690 |
Why?
|
Gastrointestinal Diseases | 3 | 2017 | 1170 | 0.690 |
Why?
|
Time Factors | 40 | 2021 | 40075 | 0.680 |
Why?
|
Tea | 2 | 2023 | 275 | 0.680 |
Why?
|
Celiac Disease | 3 | 2021 | 785 | 0.670 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 2 | 2023 | 236 | 0.670 |
Why?
|
DNA, Mitochondrial | 6 | 2020 | 817 | 0.670 |
Why?
|
Masks | 1 | 2021 | 197 | 0.660 |
Why?
|
Liver Cirrhosis | 6 | 2024 | 1863 | 0.660 |
Why?
|
Dietary Fats | 4 | 2020 | 2017 | 0.650 |
Why?
|
Tooth Loss | 4 | 2023 | 197 | 0.650 |
Why?
|
ras Proteins | 7 | 2014 | 1060 | 0.650 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2019 | 101 | 0.650 |
Why?
|
Cholangiocarcinoma | 6 | 2020 | 516 | 0.640 |
Why?
|
Bile Duct Neoplasms | 6 | 2019 | 567 | 0.640 |
Why?
|
Glucuronosyltransferase | 2 | 2011 | 128 | 0.640 |
Why?
|
Genotype | 38 | 2023 | 12951 | 0.640 |
Why?
|
Sentinel Surveillance | 1 | 2020 | 281 | 0.630 |
Why?
|
Diverticulosis, Colonic | 1 | 2017 | 8 | 0.630 |
Why?
|
Aged, 80 and over | 62 | 2023 | 57776 | 0.630 |
Why?
|
Mutation | 45 | 2023 | 29786 | 0.630 |
Why?
|
Colon | 15 | 2021 | 1772 | 0.630 |
Why?
|
Weight Gain | 11 | 2023 | 2292 | 0.630 |
Why?
|
Diet, Mediterranean | 7 | 2022 | 700 | 0.630 |
Why?
|
Leukocytes | 8 | 2022 | 2043 | 0.630 |
Why?
|
Diverticulum, Colon | 1 | 2017 | 33 | 0.630 |
Why?
|
Fatty Liver | 1 | 2024 | 727 | 0.620 |
Why?
|
Coffee | 6 | 2020 | 578 | 0.620 |
Why?
|
Diphosphonates | 2 | 2013 | 623 | 0.620 |
Why?
|
Logistic Models | 33 | 2021 | 13408 | 0.610 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 7 | 2022 | 3255 | 0.600 |
Why?
|
Genetic Variation | 17 | 2021 | 6544 | 0.590 |
Why?
|
Diet Therapy | 1 | 2018 | 154 | 0.590 |
Why?
|
C-Peptide | 9 | 2023 | 419 | 0.590 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 3 | 2009 | 257 | 0.590 |
Why?
|
Telomere | 5 | 2022 | 910 | 0.590 |
Why?
|
Long Interspersed Nucleotide Elements | 10 | 2023 | 338 | 0.590 |
Why?
|
Interleukin-6 | 8 | 2020 | 3200 | 0.580 |
Why?
|
Sex Factors | 28 | 2021 | 10397 | 0.580 |
Why?
|
Prostaglandins | 2 | 2017 | 405 | 0.580 |
Why?
|
Sulfonamides | 3 | 2011 | 1938 | 0.580 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3133 | 0.570 |
Why?
|
Fellowships and Scholarships | 2 | 2015 | 1076 | 0.570 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 15 | 2022 | 890 | 0.570 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3240 | 0.570 |
Why?
|
Nursing Research | 1 | 2017 | 77 | 0.560 |
Why?
|
Fish Oils | 2 | 2019 | 470 | 0.560 |
Why?
|
Fluorocarbons | 1 | 2021 | 452 | 0.560 |
Why?
|
Fluorouracil | 4 | 2020 | 1619 | 0.560 |
Why?
|
beta Catenin | 7 | 2020 | 1059 | 0.550 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 5 | 2016 | 357 | 0.550 |
Why?
|
Pyrazoles | 3 | 2011 | 1972 | 0.550 |
Why?
|
Waist Circumference | 7 | 2020 | 917 | 0.540 |
Why?
|
Ethanol | 3 | 2019 | 1342 | 0.540 |
Why?
|
Exercise Therapy | 3 | 2018 | 906 | 0.540 |
Why?
|
Overweight | 6 | 2022 | 2371 | 0.540 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2022 | 238 | 0.540 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2020 | 624 | 0.540 |
Why?
|
Motor Activity | 8 | 2015 | 2714 | 0.530 |
Why?
|
Age Factors | 23 | 2021 | 18370 | 0.530 |
Why?
|
Heme | 1 | 2017 | 307 | 0.520 |
Why?
|
Physicians, Primary Care | 1 | 2022 | 591 | 0.520 |
Why?
|
Phosphatidylinositol 3-Kinases | 12 | 2021 | 2938 | 0.510 |
Why?
|
Double-Blind Method | 15 | 2024 | 12026 | 0.510 |
Why?
|
Chromosomes, Human, Pair 8 | 3 | 2013 | 460 | 0.510 |
Why?
|
Alcoholic Beverages | 1 | 2016 | 265 | 0.500 |
Why?
|
Interferon-beta | 2 | 2015 | 323 | 0.500 |
Why?
|
Molecular Epidemiology | 7 | 2019 | 468 | 0.500 |
Why?
|
Folic Acid | 5 | 2022 | 1300 | 0.500 |
Why?
|
Age of Onset | 12 | 2021 | 3271 | 0.500 |
Why?
|
Receptors, Leptin | 2 | 2013 | 360 | 0.490 |
Why?
|
Calcium, Dietary | 4 | 2019 | 526 | 0.490 |
Why?
|
Hydroxyprostaglandin Dehydrogenases | 1 | 2014 | 30 | 0.490 |
Why?
|
Diet, Gluten-Free | 1 | 2017 | 271 | 0.490 |
Why?
|
Antineoplastic Agents | 7 | 2020 | 13695 | 0.490 |
Why?
|
Biliary Tract Neoplasms | 3 | 2022 | 178 | 0.470 |
Why?
|
Data Collection | 2 | 2020 | 3341 | 0.470 |
Why?
|
Drug Administration Schedule | 10 | 2018 | 4933 | 0.470 |
Why?
|
Pathology, Molecular | 5 | 2017 | 326 | 0.460 |
Why?
|
Itraconazole | 1 | 2013 | 43 | 0.450 |
Why?
|
Progestins | 3 | 2022 | 306 | 0.440 |
Why?
|
Sweden | 11 | 2023 | 1345 | 0.440 |
Why?
|
Population Surveillance | 7 | 2021 | 2616 | 0.440 |
Why?
|
Seasons | 3 | 2016 | 1493 | 0.440 |
Why?
|
Education, Medical, Graduate | 2 | 2015 | 2291 | 0.440 |
Why?
|
Mass Screening | 9 | 2022 | 5255 | 0.440 |
Why?
|
Cladribine | 2 | 2022 | 34 | 0.440 |
Why?
|
Demography | 2 | 2015 | 1656 | 0.440 |
Why?
|
Barrett Esophagus | 2 | 2015 | 494 | 0.440 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2012 | 56 | 0.440 |
Why?
|
Periodontal Diseases | 3 | 2023 | 449 | 0.430 |
Why?
|
Cecal Neoplasms | 2 | 2012 | 29 | 0.430 |
Why?
|
Dairy Products | 3 | 2021 | 498 | 0.430 |
Why?
|
Peptic Ulcer | 1 | 2014 | 223 | 0.430 |
Why?
|
Flavonoids | 3 | 2023 | 443 | 0.430 |
Why?
|
Cognition Disorders | 2 | 2017 | 4043 | 0.430 |
Why?
|
Neoplasm Staging | 25 | 2022 | 11031 | 0.420 |
Why?
|
T-Lymphocytes | 8 | 2019 | 10180 | 0.420 |
Why?
|
Genomics | 7 | 2022 | 5720 | 0.420 |
Why?
|
Metagenome | 4 | 2023 | 418 | 0.420 |
Why?
|
HSP110 Heat-Shock Proteins | 1 | 2011 | 10 | 0.420 |
Why?
|
Gene Expression | 8 | 2022 | 7799 | 0.420 |
Why?
|
Medical History Taking | 5 | 2019 | 783 | 0.410 |
Why?
|
Liver Diseases | 1 | 2020 | 1253 | 0.410 |
Why?
|
Leptin | 3 | 2018 | 1599 | 0.400 |
Why?
|
DNA Copy Number Variations | 5 | 2020 | 1941 | 0.400 |
Why?
|
Young Adult | 41 | 2024 | 56430 | 0.400 |
Why?
|
Constipation | 3 | 2023 | 546 | 0.400 |
Why?
|
Rectum | 9 | 2020 | 904 | 0.400 |
Why?
|
Testosterone | 5 | 2022 | 2420 | 0.400 |
Why?
|
ABO Blood-Group System | 2 | 2011 | 367 | 0.400 |
Why?
|
Zinc | 1 | 2015 | 684 | 0.400 |
Why?
|
DNA Glycosylases | 2 | 2022 | 128 | 0.390 |
Why?
|
Adenomatous Polyposis Coli | 2 | 2011 | 224 | 0.390 |
Why?
|
Lignans | 2 | 2022 | 81 | 0.390 |
Why?
|
Food, Fortified | 2 | 2015 | 191 | 0.390 |
Why?
|
Biomedical Research | 4 | 2021 | 3309 | 0.380 |
Why?
|
Fatty Acids | 2 | 2022 | 1809 | 0.380 |
Why?
|
Phenotype | 27 | 2023 | 16365 | 0.370 |
Why?
|
Cathepsin B | 1 | 2010 | 82 | 0.370 |
Why?
|
Secondary Prevention | 2 | 2015 | 1530 | 0.370 |
Why?
|
Pandemics | 11 | 2022 | 8388 | 0.370 |
Why?
|
Adolescent | 38 | 2024 | 85781 | 0.360 |
Why?
|
Waist-Hip Ratio | 5 | 2020 | 517 | 0.360 |
Why?
|
Receptors, CXCR4 | 1 | 2015 | 726 | 0.360 |
Why?
|
Peptides | 3 | 2024 | 4409 | 0.360 |
Why?
|
Skin Neoplasms | 4 | 2022 | 5686 | 0.360 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2014 | 1213 | 0.360 |
Why?
|
Survival Analysis | 18 | 2022 | 10252 | 0.350 |
Why?
|
Health Occupations | 3 | 2021 | 224 | 0.350 |
Why?
|
Bifidobacterium | 2 | 2021 | 100 | 0.350 |
Why?
|
Histamine H2 Antagonists | 3 | 2020 | 165 | 0.350 |
Why?
|
Metabolome | 3 | 2020 | 895 | 0.350 |
Why?
|
Fusobacterium Infections | 2 | 2021 | 53 | 0.340 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2022 | 434 | 0.340 |
Why?
|
Metagenomics | 4 | 2021 | 428 | 0.340 |
Why?
|
Minerals | 1 | 2010 | 275 | 0.330 |
Why?
|
Cause of Death | 9 | 2022 | 3584 | 0.330 |
Why?
|
Metformin | 1 | 2016 | 835 | 0.330 |
Why?
|
Hip Fractures | 2 | 2020 | 955 | 0.330 |
Why?
|
Ovarian Neoplasms | 6 | 2023 | 4838 | 0.320 |
Why?
|
Dose-Response Relationship, Drug | 10 | 2015 | 10943 | 0.320 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2022 | 4479 | 0.320 |
Why?
|
Public Health | 4 | 2023 | 2603 | 0.320 |
Why?
|
Liver | 1 | 2024 | 7474 | 0.320 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2016 | 990 | 0.320 |
Why?
|
Disease-Free Survival | 7 | 2023 | 6895 | 0.310 |
Why?
|
Adenosine Triphosphate | 2 | 2015 | 2025 | 0.310 |
Why?
|
Specimen Handling | 3 | 2022 | 694 | 0.310 |
Why?
|
Adjuvants, Immunologic | 1 | 2013 | 1000 | 0.310 |
Why?
|
Epidemiologic Studies | 7 | 2022 | 676 | 0.300 |
Why?
|
Proto-Oncogene Proteins | 7 | 2014 | 4554 | 0.300 |
Why?
|
Kaplan-Meier Estimate | 16 | 2020 | 6538 | 0.300 |
Why?
|
Placebos | 4 | 2020 | 1676 | 0.290 |
Why?
|
Laxatives | 2 | 2021 | 87 | 0.290 |
Why?
|
Patient Admission | 1 | 2015 | 1380 | 0.290 |
Why?
|
Self Report | 11 | 2022 | 3558 | 0.290 |
Why?
|
Family | 1 | 2018 | 3147 | 0.290 |
Why?
|
Eating | 4 | 2020 | 1536 | 0.290 |
Why?
|
Fatty Acids, Unsaturated | 2 | 2020 | 546 | 0.290 |
Why?
|
Colitis, Lymphocytic | 2 | 2018 | 25 | 0.290 |
Why?
|
Colitis, Collagenous | 2 | 2018 | 26 | 0.290 |
Why?
|
Genetic Heterogeneity | 2 | 2021 | 733 | 0.290 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2010 | 640 | 0.280 |
Why?
|
Escherichia coli | 2 | 2022 | 4217 | 0.280 |
Why?
|
Heterozygote | 2 | 2022 | 2804 | 0.280 |
Why?
|
Mitochondria | 3 | 2020 | 3520 | 0.280 |
Why?
|
DNA, Bacterial | 5 | 2018 | 1465 | 0.280 |
Why?
|
Periodicals as Topic | 1 | 2017 | 1432 | 0.280 |
Why?
|
Survival Rate | 17 | 2020 | 12788 | 0.280 |
Why?
|
Coronary Disease | 2 | 2021 | 6077 | 0.280 |
Why?
|
Treatment Outcome | 23 | 2023 | 63114 | 0.270 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2012 | 3336 | 0.270 |
Why?
|
Cholelithiasis | 2 | 2021 | 414 | 0.270 |
Why?
|
Caffeine | 3 | 2020 | 699 | 0.270 |
Why?
|
Software | 1 | 2020 | 4443 | 0.270 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2020 | 8428 | 0.270 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2019 | 563 | 0.270 |
Why?
|
Diet, Vegetarian | 3 | 2022 | 174 | 0.260 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 5 | 2017 | 3870 | 0.260 |
Why?
|
Comorbidity | 5 | 2021 | 10388 | 0.260 |
Why?
|
Proteomics | 5 | 2022 | 3638 | 0.260 |
Why?
|
Gonadal Steroid Hormones | 3 | 2021 | 712 | 0.250 |
Why?
|
Genetic Pleiotropy | 2 | 2018 | 182 | 0.250 |
Why?
|
Internship and Residency | 2 | 2015 | 5788 | 0.250 |
Why?
|
4-Butyrolactone | 2 | 2022 | 63 | 0.250 |
Why?
|
Germ-Line Mutation | 5 | 2022 | 1788 | 0.250 |
Why?
|
Immunohistochemistry | 14 | 2021 | 11366 | 0.250 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 4 | 2019 | 424 | 0.240 |
Why?
|
Gastrointestinal Agents | 2 | 2021 | 494 | 0.240 |
Why?
|
Audiovisual Aids | 1 | 2005 | 92 | 0.240 |
Why?
|
Alleles | 11 | 2021 | 6933 | 0.240 |
Why?
|
Bile Ducts, Intrahepatic | 4 | 2020 | 295 | 0.230 |
Why?
|
Environmental Exposure | 1 | 2018 | 4234 | 0.230 |
Why?
|
Insulin | 8 | 2022 | 6580 | 0.230 |
Why?
|
Forkhead Transcription Factors | 4 | 2020 | 1613 | 0.230 |
Why?
|
Methylamines | 2 | 2021 | 123 | 0.230 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2006 | 675 | 0.230 |
Why?
|
Models, Statistical | 6 | 2021 | 5102 | 0.230 |
Why?
|
Quantitative Trait Loci | 4 | 2020 | 2019 | 0.230 |
Why?
|
Brain Ischemia | 1 | 2017 | 3265 | 0.230 |
Why?
|
Epigenomics | 4 | 2017 | 903 | 0.230 |
Why?
|
Blood Glucose | 4 | 2022 | 6256 | 0.230 |
Why?
|
Registries | 11 | 2021 | 8089 | 0.230 |
Why?
|
Diarrhea | 2 | 2023 | 1348 | 0.230 |
Why?
|
Quality Indicators, Health Care | 1 | 2013 | 1831 | 0.220 |
Why?
|
Colectomy | 3 | 2020 | 683 | 0.220 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2727 | 0.220 |
Why?
|
Huntington Disease | 1 | 2010 | 1124 | 0.220 |
Why?
|
Encephalitis | 1 | 2006 | 423 | 0.220 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 3 | 2019 | 123 | 0.220 |
Why?
|
Epigenesis, Genetic | 6 | 2021 | 3647 | 0.220 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2023 | 9959 | 0.220 |
Why?
|
Biology | 1 | 2005 | 294 | 0.210 |
Why?
|
Estrogens | 3 | 2022 | 1566 | 0.210 |
Why?
|
Estradiol | 5 | 2022 | 2020 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2023 | 9239 | 0.210 |
Why?
|
Propionates | 1 | 2023 | 169 | 0.210 |
Why?
|
Hypertension | 4 | 2022 | 8480 | 0.210 |
Why?
|
T-Lymphocyte Subsets | 2 | 2021 | 1838 | 0.210 |
Why?
|
Genes, ras | 3 | 2021 | 690 | 0.210 |
Why?
|
Moyamoya Disease | 1 | 2005 | 238 | 0.210 |
Why?
|
Microglia | 3 | 2007 | 1266 | 0.210 |
Why?
|
Butyrates | 1 | 2023 | 163 | 0.210 |
Why?
|
Diabetes Mellitus | 3 | 2022 | 5751 | 0.210 |
Why?
|
Sleep | 2 | 2017 | 4623 | 0.210 |
Why?
|
Confidence Intervals | 6 | 2021 | 2971 | 0.210 |
Why?
|
Principal Component Analysis | 4 | 2022 | 940 | 0.210 |
Why?
|
Salicylic Acid | 1 | 2021 | 56 | 0.210 |
Why?
|
Acetaminophen | 1 | 2006 | 545 | 0.200 |
Why?
|
Drug Discovery | 2 | 2010 | 1058 | 0.200 |
Why?
|
Keloid | 1 | 2022 | 50 | 0.200 |
Why?
|
Thoracic Neoplasms | 1 | 2004 | 268 | 0.200 |
Why?
|
Meat Products | 2 | 2019 | 99 | 0.200 |
Why?
|
MicroRNAs | 5 | 2016 | 3752 | 0.200 |
Why?
|
Ageusia | 1 | 2021 | 20 | 0.200 |
Why?
|
Neuropsychological Tests | 3 | 2022 | 6993 | 0.200 |
Why?
|
Menopause | 5 | 2022 | 1626 | 0.200 |
Why?
|
Fusobacterium | 1 | 2021 | 54 | 0.200 |
Why?
|
Biliary Tract | 1 | 2022 | 134 | 0.200 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 8 | 2022 | 11524 | 0.200 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 25043 | 0.200 |
Why?
|
Hemorrhage | 3 | 2023 | 3461 | 0.190 |
Why?
|
Insulin-Like Growth Factor I | 4 | 2019 | 2015 | 0.190 |
Why?
|
Monosaccharides | 1 | 2021 | 70 | 0.190 |
Why?
|
Longitudinal Studies | 11 | 2020 | 13989 | 0.190 |
Why?
|
Psychomotor Agitation | 1 | 2023 | 293 | 0.190 |
Why?
|
Prescription Drugs | 2 | 2020 | 595 | 0.190 |
Why?
|
Immunotherapy | 1 | 2016 | 4445 | 0.190 |
Why?
|
Phagocytosis | 1 | 2006 | 1539 | 0.190 |
Why?
|
Lymphocytes | 3 | 2020 | 2617 | 0.190 |
Why?
|
Chronic Disease | 6 | 2023 | 9146 | 0.190 |
Why?
|
Somatotypes | 1 | 2020 | 41 | 0.190 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2005 | 500 | 0.190 |
Why?
|
Animals | 29 | 2023 | 168757 | 0.190 |
Why?
|
Cadherins | 2 | 2016 | 907 | 0.190 |
Why?
|
Latent Tuberculosis | 1 | 2023 | 225 | 0.190 |
Why?
|
Ferritins | 3 | 2023 | 590 | 0.190 |
Why?
|
Databases, Genetic | 6 | 2022 | 1783 | 0.190 |
Why?
|
Fast Foods | 1 | 2022 | 197 | 0.180 |
Why?
|
Adenoma, Villous | 1 | 2020 | 15 | 0.180 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7279 | 0.180 |
Why?
|
Nuts | 2 | 2019 | 257 | 0.180 |
Why?
|
Hydrogen Sulfide | 1 | 2021 | 137 | 0.180 |
Why?
|
Up-Regulation | 7 | 2019 | 4217 | 0.180 |
Why?
|
Computational Biology | 5 | 2020 | 3521 | 0.180 |
Why?
|
Gastrointestinal Tract | 3 | 2015 | 814 | 0.180 |
Why?
|
End Stage Liver Disease | 1 | 2024 | 314 | 0.180 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2023 | 841 | 0.180 |
Why?
|
Models, Biological | 4 | 2021 | 9583 | 0.180 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2019 | 34 | 0.180 |
Why?
|
Gastrointestinal Motility | 1 | 2021 | 225 | 0.180 |
Why?
|
Eicosapentaenoic Acid | 2 | 2023 | 582 | 0.170 |
Why?
|
Research Design | 8 | 2019 | 5987 | 0.170 |
Why?
|
Vaccination | 2 | 2022 | 3278 | 0.170 |
Why?
|
Age Distribution | 5 | 2021 | 2902 | 0.170 |
Why?
|
Plants, Medicinal | 1 | 2020 | 167 | 0.170 |
Why?
|
RNA, Messenger | 11 | 2023 | 13033 | 0.170 |
Why?
|
Melanoma | 3 | 2022 | 5510 | 0.170 |
Why?
|
Fatty Acid Desaturases | 1 | 2019 | 102 | 0.170 |
Why?
|
DNA, Neoplasm | 4 | 2013 | 1758 | 0.170 |
Why?
|
Hepatitis C, Chronic | 2 | 2020 | 1031 | 0.170 |
Why?
|
Gastric Mucosa | 1 | 2022 | 599 | 0.170 |
Why?
|
Granulocytes | 1 | 2021 | 548 | 0.170 |
Why?
|
Caloric Restriction | 1 | 2021 | 302 | 0.170 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3610 | 0.170 |
Why?
|
Predictive Value of Tests | 6 | 2021 | 15076 | 0.170 |
Why?
|
Prevalence | 8 | 2023 | 15226 | 0.170 |
Why?
|
Bifidobacteriales Infections | 1 | 2018 | 10 | 0.170 |
Why?
|
Models, Genetic | 3 | 2020 | 3494 | 0.170 |
Why?
|
Paraffin Embedding | 1 | 2020 | 299 | 0.170 |
Why?
|
Depression | 2 | 2023 | 7766 | 0.170 |
Why?
|
Fishes | 3 | 2019 | 569 | 0.170 |
Why?
|
Estrone | 1 | 2020 | 240 | 0.170 |
Why?
|
Tissue Fixation | 1 | 2020 | 241 | 0.170 |
Why?
|
China | 3 | 2020 | 2248 | 0.170 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2020 | 188 | 0.170 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2005 | 1366 | 0.170 |
Why?
|
Genital Neoplasms, Female | 1 | 2004 | 523 | 0.160 |
Why?
|
Microsatellite Repeats | 3 | 2015 | 802 | 0.160 |
Why?
|
Bilirubin | 1 | 2020 | 425 | 0.160 |
Why?
|
Disease Susceptibility | 3 | 2021 | 1782 | 0.160 |
Why?
|
Arachidonic Acid | 1 | 2020 | 434 | 0.160 |
Why?
|
Natural Killer T-Cells | 1 | 2021 | 316 | 0.160 |
Why?
|
Haplotypes | 3 | 2016 | 2779 | 0.160 |
Why?
|
Genetic Association Studies | 7 | 2018 | 2703 | 0.160 |
Why?
|
Formaldehyde | 1 | 2020 | 353 | 0.160 |
Why?
|
Glucosinolates | 1 | 2018 | 10 | 0.160 |
Why?
|
Breast Neoplasms | 7 | 2020 | 20822 | 0.160 |
Why?
|
Polyps | 1 | 2020 | 189 | 0.160 |
Why?
|
Escherichia coli Infections | 1 | 2022 | 532 | 0.160 |
Why?
|
Germany | 6 | 2018 | 862 | 0.160 |
Why?
|
Micronutrients | 1 | 2021 | 375 | 0.160 |
Why?
|
Smad4 Protein | 1 | 2018 | 163 | 0.160 |
Why?
|
Nutritional Status | 2 | 2018 | 1609 | 0.160 |
Why?
|
Gallbladder Neoplasms | 1 | 2019 | 183 | 0.160 |
Why?
|
Fatty Acids, Omega-6 | 2 | 2022 | 227 | 0.160 |
Why?
|
Isothiocyanates | 1 | 2018 | 51 | 0.160 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2018 | 83 | 0.160 |
Why?
|
Disease Progression | 9 | 2019 | 13284 | 0.160 |
Why?
|
Massachusetts | 4 | 2021 | 8663 | 0.160 |
Why?
|
Pharmacogenetics | 2 | 2015 | 675 | 0.160 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2021 | 262 | 0.160 |
Why?
|
Lymphocyte Count | 5 | 2020 | 793 | 0.160 |
Why?
|
Beverages | 2 | 2022 | 820 | 0.150 |
Why?
|
Metabolomics | 3 | 2021 | 1484 | 0.150 |
Why?
|
Cough | 1 | 2021 | 555 | 0.150 |
Why?
|
Drug Eruptions | 1 | 2020 | 297 | 0.150 |
Why?
|
MAP Kinase Signaling System | 1 | 2005 | 1526 | 0.150 |
Why?
|
Obesity, Abdominal | 2 | 2018 | 361 | 0.150 |
Why?
|
Insulin-Like Growth Factor II | 2 | 2019 | 271 | 0.150 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.150 |
Why?
|
Poultry Products | 1 | 2017 | 10 | 0.150 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2020 | 415 | 0.150 |
Why?
|
Smoke | 1 | 2019 | 227 | 0.150 |
Why?
|
Blood Pressure | 1 | 2013 | 8554 | 0.150 |
Why?
|
Fish Products | 1 | 2017 | 29 | 0.150 |
Why?
|
Pancreatic Neoplasms | 4 | 2022 | 5256 | 0.150 |
Why?
|
Australia | 4 | 2023 | 1170 | 0.150 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15540 | 0.150 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2019 | 251 | 0.150 |
Why?
|
Biological Availability | 1 | 2018 | 397 | 0.150 |
Why?
|
Cultural Diversity | 1 | 2020 | 359 | 0.150 |
Why?
|
Sex Distribution | 4 | 2015 | 2297 | 0.150 |
Why?
|
Signal Transduction | 7 | 2018 | 23403 | 0.140 |
Why?
|
Estrogen Receptor beta | 2 | 2020 | 175 | 0.140 |
Why?
|
Aptamers, Nucleotide | 1 | 2018 | 166 | 0.140 |
Why?
|
Iron | 1 | 2005 | 1774 | 0.140 |
Why?
|
Gene Frequency | 7 | 2019 | 3588 | 0.140 |
Why?
|
Beer | 1 | 2016 | 127 | 0.140 |
Why?
|
Inheritance Patterns | 1 | 2019 | 340 | 0.140 |
Why?
|
Dyspnea | 2 | 2021 | 1303 | 0.140 |
Why?
|
Chondroitin | 1 | 2016 | 66 | 0.140 |
Why?
|
Mitoxantrone | 1 | 2016 | 152 | 0.140 |
Why?
|
Plasma | 2 | 2019 | 575 | 0.140 |
Why?
|
Pancreatic Pseudocyst | 1 | 1996 | 110 | 0.140 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3047 | 0.140 |
Why?
|
Plasminogen | 1 | 2016 | 152 | 0.140 |
Why?
|
Glucosamine | 1 | 2016 | 132 | 0.140 |
Why?
|
Wine | 1 | 2016 | 165 | 0.140 |
Why?
|
Hormones | 1 | 2020 | 889 | 0.140 |
Why?
|
Plants, Edible | 1 | 2015 | 30 | 0.140 |
Why?
|
Drug Utilization | 3 | 2019 | 1183 | 0.140 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2017 | 315 | 0.130 |
Why?
|
Respiratory Tract Diseases | 1 | 2021 | 722 | 0.130 |
Why?
|
Receptor, Melanocortin, Type 4 | 1 | 2016 | 129 | 0.130 |
Why?
|
Calcium | 3 | 2019 | 5756 | 0.130 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2013 | 518 | 0.130 |
Why?
|
Selection Bias | 1 | 2017 | 371 | 0.130 |
Why?
|
Polymorphism, Genetic | 5 | 2011 | 4328 | 0.130 |
Why?
|
Transcription Factor 7-Like 2 Protein | 2 | 2013 | 154 | 0.130 |
Why?
|
Disease Transmission, Infectious | 1 | 2021 | 547 | 0.130 |
Why?
|
Hepatitis B, Chronic | 1 | 2020 | 393 | 0.130 |
Why?
|
Bismuth | 1 | 2015 | 29 | 0.130 |
Why?
|
Communicable Disease Control | 1 | 2022 | 857 | 0.130 |
Why?
|
Organoids | 1 | 2021 | 701 | 0.130 |
Why?
|
Cyclin D1 | 2 | 2008 | 463 | 0.130 |
Why?
|
Job Description | 1 | 2015 | 58 | 0.130 |
Why?
|
Menarche | 1 | 2018 | 516 | 0.130 |
Why?
|
Rosacea | 1 | 2015 | 49 | 0.130 |
Why?
|
Tetracycline | 1 | 2015 | 214 | 0.130 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2016 | 380 | 0.130 |
Why?
|
Aging | 5 | 2021 | 8664 | 0.130 |
Why?
|
Stroke | 1 | 2017 | 9981 | 0.130 |
Why?
|
Allied Health Personnel | 1 | 2016 | 162 | 0.130 |
Why?
|
Coffea | 1 | 2014 | 22 | 0.130 |
Why?
|
Salicylates | 1 | 2015 | 126 | 0.130 |
Why?
|
Cholesterol | 2 | 2022 | 2917 | 0.130 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2015 | 299 | 0.130 |
Why?
|
Androgens | 1 | 2022 | 1281 | 0.130 |
Why?
|
Folic Acid Deficiency | 1 | 2015 | 115 | 0.130 |
Why?
|
Lung Neoplasms | 5 | 2019 | 13102 | 0.120 |
Why?
|
Diet Records | 1 | 2016 | 425 | 0.120 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2016 | 314 | 0.120 |
Why?
|
Child, Preschool | 7 | 2022 | 41006 | 0.120 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2010 | 3523 | 0.120 |
Why?
|
Ultraviolet Rays | 2 | 2021 | 1060 | 0.120 |
Why?
|
Prostatic Neoplasms | 4 | 2019 | 11124 | 0.120 |
Why?
|
Tumor Escape | 1 | 2017 | 349 | 0.120 |
Why?
|
Antibiotic Prophylaxis | 1 | 2019 | 639 | 0.120 |
Why?
|
Progesterone | 1 | 2019 | 776 | 0.120 |
Why?
|
Anthropometry | 1 | 2019 | 1350 | 0.120 |
Why?
|
Gene Expression Profiling | 4 | 2018 | 9438 | 0.120 |
Why?
|
Calcium Signaling | 1 | 2019 | 721 | 0.120 |
Why?
|
Budesonide | 1 | 2015 | 154 | 0.120 |
Why?
|
Recurrence | 2 | 2020 | 8340 | 0.120 |
Why?
|
Plant Proteins | 1 | 2016 | 364 | 0.120 |
Why?
|
Nonprescription Drugs | 1 | 2015 | 116 | 0.120 |
Why?
|
Endometriosis | 1 | 2022 | 839 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2021 | 2942 | 0.120 |
Why?
|
Body Fat Distribution | 1 | 2015 | 244 | 0.120 |
Why?
|
Graft vs Leukemia Effect | 1 | 2014 | 111 | 0.120 |
Why?
|
Retrospective Studies | 14 | 2021 | 77449 | 0.120 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 2988 | 0.120 |
Why?
|
Receptors, Interleukin-6 | 1 | 2015 | 224 | 0.120 |
Why?
|
Hydrochlorothiazide | 1 | 2014 | 98 | 0.120 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2017 | 794 | 0.120 |
Why?
|
Indiana | 1 | 2013 | 92 | 0.120 |
Why?
|
Preventive Medicine | 1 | 2015 | 264 | 0.120 |
Why?
|
alpha-Mannosidase | 1 | 2013 | 20 | 0.120 |
Why?
|
Prostaglandin Antagonists | 1 | 2013 | 30 | 0.120 |
Why?
|
Fever | 1 | 2021 | 1616 | 0.120 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2012 | 365 | 0.120 |
Why?
|
Cell Proliferation | 4 | 2020 | 10481 | 0.120 |
Why?
|
Anemia | 1 | 2023 | 1506 | 0.120 |
Why?
|
Infusions, Subcutaneous | 1 | 2013 | 42 | 0.110 |
Why?
|
Neoplasm Proteins | 3 | 2020 | 3703 | 0.110 |
Why?
|
International Cooperation | 1 | 2020 | 1420 | 0.110 |
Why?
|
SOXE Transcription Factors | 1 | 2013 | 57 | 0.110 |
Why?
|
Ankyrin Repeat | 1 | 2013 | 17 | 0.110 |
Why?
|
Protein Interaction Mapping | 1 | 2017 | 627 | 0.110 |
Why?
|
Geriatric Assessment | 1 | 2021 | 1372 | 0.110 |
Why?
|
Europe | 4 | 2023 | 3339 | 0.110 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2013 | 104 | 0.110 |
Why?
|
Receptors, CXCR5 | 1 | 2013 | 92 | 0.110 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2023 | 868 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 9 | 2014 | 4751 | 0.110 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2018 | 477 | 0.110 |
Why?
|
Databases, Factual | 7 | 2019 | 7729 | 0.110 |
Why?
|
Research Report | 1 | 2016 | 355 | 0.110 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2010 | 835 | 0.110 |
Why?
|
Calcifediol | 1 | 2013 | 166 | 0.110 |
Why?
|
Socioeconomic Factors | 3 | 2021 | 7785 | 0.110 |
Why?
|
Boston | 3 | 2017 | 9313 | 0.110 |
Why?
|
Cyclin D2 | 1 | 2012 | 101 | 0.110 |
Why?
|
Choline | 2 | 2021 | 493 | 0.110 |
Why?
|
Vitamin B Complex | 1 | 2015 | 288 | 0.110 |
Why?
|
JC Virus | 1 | 2013 | 85 | 0.110 |
Why?
|
Receptors, Interleukin | 1 | 2014 | 245 | 0.110 |
Why?
|
Kallikreins | 1 | 2014 | 258 | 0.110 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2017 | 604 | 0.110 |
Why?
|
Clinical Protocols | 2 | 2017 | 1462 | 0.110 |
Why?
|
Walking | 1 | 2020 | 1180 | 0.110 |
Why?
|
Immunologic Factors | 2 | 2015 | 1580 | 0.110 |
Why?
|
Body Height | 2 | 2018 | 1577 | 0.110 |
Why?
|
Biopsy | 4 | 2020 | 6756 | 0.110 |
Why?
|
Forecasting | 1 | 2022 | 2951 | 0.110 |
Why?
|
Television | 1 | 2015 | 409 | 0.110 |
Why?
|
Cisplatin | 1 | 2018 | 1662 | 0.110 |
Why?
|
Weight Loss | 1 | 2024 | 2622 | 0.110 |
Why?
|
Biostatistics | 1 | 2014 | 162 | 0.110 |
Why?
|
Codon | 1 | 2014 | 611 | 0.110 |
Why?
|
Wnt Proteins | 2 | 2013 | 721 | 0.110 |
Why?
|
Adolescent Behavior | 1 | 2021 | 1151 | 0.110 |
Why?
|
Tablets | 2 | 2022 | 145 | 0.100 |
Why?
|
Energy Intake | 2 | 2017 | 2148 | 0.100 |
Why?
|
Catechol O-Methyltransferase | 1 | 2014 | 245 | 0.100 |
Why?
|
Proteins | 4 | 2023 | 6103 | 0.100 |
Why?
|
Serum | 1 | 2013 | 214 | 0.100 |
Why?
|
Plant Extracts | 1 | 2015 | 471 | 0.100 |
Why?
|
3' Untranslated Regions | 1 | 2014 | 513 | 0.100 |
Why?
|
Disability Evaluation | 2 | 2016 | 1827 | 0.100 |
Why?
|
Autophagy | 1 | 2020 | 1300 | 0.100 |
Why?
|
Nutritive Value | 1 | 2015 | 339 | 0.100 |
Why?
|
Health Status | 3 | 2023 | 4034 | 0.100 |
Why?
|
Receptors, Calcitriol | 1 | 2014 | 350 | 0.100 |
Why?
|
Quality Control | 1 | 2014 | 841 | 0.100 |
Why?
|
Receptors, Ghrelin | 1 | 2011 | 25 | 0.100 |
Why?
|
DEAD-box RNA Helicases | 1 | 2014 | 375 | 0.100 |
Why?
|
Government Programs | 1 | 2014 | 275 | 0.100 |
Why?
|
Cooking | 1 | 2014 | 313 | 0.100 |
Why?
|
Hospitals, University | 1 | 2013 | 571 | 0.100 |
Why?
|
Host-Pathogen Interactions | 3 | 2015 | 1477 | 0.100 |
Why?
|
Down-Regulation | 3 | 2012 | 3002 | 0.100 |
Why?
|
Neuromyelitis Optica | 1 | 2015 | 252 | 0.100 |
Why?
|
Monocytes | 1 | 2021 | 2596 | 0.100 |
Why?
|
Hypercalcemia | 1 | 2014 | 409 | 0.100 |
Why?
|
Organometallic Compounds | 1 | 2015 | 665 | 0.100 |
Why?
|
Dietary Proteins | 1 | 2016 | 963 | 0.100 |
Why?
|
Mice, Inbred BALB C | 2 | 2018 | 6386 | 0.100 |
Why?
|
Cell Lineage | 1 | 2020 | 2504 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2020 | 3597 | 0.100 |
Why?
|
Sensitivity and Specificity | 3 | 2021 | 14722 | 0.100 |
Why?
|
Intestinal Mucosa | 3 | 2020 | 3036 | 0.100 |
Why?
|
Antioxidants | 2 | 2019 | 1663 | 0.100 |
Why?
|
Erythrocytes | 1 | 2020 | 2455 | 0.090 |
Why?
|
Polyomavirus Infections | 1 | 2013 | 197 | 0.090 |
Why?
|
Chi-Square Distribution | 3 | 2014 | 3508 | 0.090 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2013 | 893 | 0.090 |
Why?
|
Membrane Transport Proteins | 1 | 2016 | 1028 | 0.090 |
Why?
|
Helicobacter pylori | 1 | 2014 | 382 | 0.090 |
Why?
|
Drainage | 1 | 1996 | 1142 | 0.090 |
Why?
|
Digestive System Surgical Procedures | 1 | 2016 | 576 | 0.090 |
Why?
|
Demyelinating Diseases | 1 | 2013 | 354 | 0.090 |
Why?
|
Smoking Cessation | 4 | 2018 | 2071 | 0.090 |
Why?
|
Internet | 2 | 2020 | 3064 | 0.090 |
Why?
|
Carrier Proteins | 2 | 2015 | 5021 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2015 | 713 | 0.090 |
Why?
|
Epistasis, Genetic | 1 | 2012 | 365 | 0.090 |
Why?
|
Linear Models | 2 | 2017 | 5952 | 0.090 |
Why?
|
Receptors, Prostaglandin E | 1 | 2010 | 56 | 0.090 |
Why?
|
Nephrolithiasis | 1 | 2011 | 110 | 0.090 |
Why?
|
Vitamin B 12 | 3 | 2021 | 527 | 0.090 |
Why?
|
Blood Donors | 1 | 2012 | 355 | 0.090 |
Why?
|
Epidemiology | 1 | 2013 | 287 | 0.090 |
Why?
|
Disease | 1 | 2015 | 680 | 0.090 |
Why?
|
Arthroplasty, Replacement | 1 | 2014 | 339 | 0.090 |
Why?
|
Immunosuppressive Agents | 3 | 2022 | 4149 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 2 | 2019 | 2849 | 0.090 |
Why?
|
HLA Antigens | 1 | 2015 | 1381 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 1999 | 1239 | 0.090 |
Why?
|
DNA Repair | 1 | 2019 | 2046 | 0.090 |
Why?
|
Colitis | 1 | 2018 | 1170 | 0.090 |
Why?
|
Markov Chains | 1 | 2013 | 969 | 0.090 |
Why?
|
Reproducibility of Results | 8 | 2022 | 19905 | 0.090 |
Why?
|
Intellectual Property | 1 | 2009 | 31 | 0.090 |
Why?
|
Arthritis, Psoriatic | 1 | 2012 | 215 | 0.090 |
Why?
|
HLA-DR Antigens | 2 | 2021 | 645 | 0.090 |
Why?
|
Geography | 1 | 2012 | 669 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 3 | 2001 | 934 | 0.090 |
Why?
|
Lymphocyte Activation | 3 | 2016 | 5524 | 0.090 |
Why?
|
Keratins | 2 | 2001 | 515 | 0.090 |
Why?
|
Ghrelin | 1 | 2011 | 266 | 0.090 |
Why?
|
Stathmin | 1 | 2009 | 71 | 0.090 |
Why?
|
Heart Diseases | 1 | 2022 | 2788 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 1114 | 0.080 |
Why?
|
Patient Compliance | 1 | 2020 | 2684 | 0.080 |
Why?
|
Promoter Regions, Genetic | 3 | 2020 | 5867 | 0.080 |
Why?
|
Causality | 3 | 2021 | 1275 | 0.080 |
Why?
|
Central Nervous System Stimulants | 1 | 2017 | 1148 | 0.080 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1901 | 0.080 |
Why?
|
Membrane Proteins | 2 | 2005 | 7880 | 0.080 |
Why?
|
Osteopontin | 2 | 2008 | 296 | 0.080 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2019 | 658 | 0.080 |
Why?
|
INDEL Mutation | 2 | 2020 | 279 | 0.080 |
Why?
|
Probability | 2 | 2017 | 2505 | 0.080 |
Why?
|
Integrin alpha4 | 1 | 2008 | 92 | 0.080 |
Why?
|
Career Choice | 1 | 2015 | 744 | 0.080 |
Why?
|
Neoplasm Metastasis | 6 | 2020 | 4851 | 0.080 |
Why?
|
Models, Theoretical | 2 | 2020 | 3589 | 0.080 |
Why?
|
Drug Therapy, Combination | 4 | 2016 | 6489 | 0.080 |
Why?
|
Somatomedins | 1 | 2008 | 192 | 0.080 |
Why?
|
Rats, Inbred Lew | 2 | 2007 | 1162 | 0.080 |
Why?
|
Public-Private Sector Partnerships | 1 | 2009 | 121 | 0.080 |
Why?
|
Mental Health | 1 | 2022 | 3019 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2214 | 0.080 |
Why?
|
Adipose Tissue | 1 | 2020 | 3279 | 0.080 |
Why?
|
TCF Transcription Factors | 1 | 2008 | 140 | 0.080 |
Why?
|
Immunoglobulin M | 2 | 2023 | 1537 | 0.080 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2014 | 604 | 0.080 |
Why?
|
Body Weight | 3 | 2024 | 4669 | 0.080 |
Why?
|
Genetic Markers | 4 | 2021 | 2634 | 0.080 |
Why?
|
Tissue Array Analysis | 3 | 2015 | 553 | 0.080 |
Why?
|
Shoulder Joint | 1 | 2014 | 695 | 0.080 |
Why?
|
Flavanones | 2 | 2019 | 71 | 0.080 |
Why?
|
Memory | 1 | 2017 | 2174 | 0.070 |
Why?
|
STAT3 Transcription Factor | 1 | 2011 | 873 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 1 | 2022 | 3143 | 0.070 |
Why?
|
Hyperplasia | 3 | 2020 | 1185 | 0.070 |
Why?
|
Betaine | 1 | 2007 | 87 | 0.070 |
Why?
|
Thrombosis | 2 | 2016 | 2968 | 0.070 |
Why?
|
Genome, Human | 1 | 2020 | 4420 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2021 | 3864 | 0.070 |
Why?
|
Benchmarking | 1 | 2013 | 1042 | 0.070 |
Why?
|
Natural Language Processing | 1 | 2015 | 1041 | 0.070 |
Why?
|
Schools | 1 | 2015 | 1433 | 0.070 |
Why?
|
DNA Mutational Analysis | 3 | 2022 | 4186 | 0.070 |
Why?
|
Academies and Institutes | 1 | 2009 | 317 | 0.070 |
Why?
|
Gelatinases | 1 | 2006 | 94 | 0.070 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2014 | 1222 | 0.070 |
Why?
|
Antibodies, Viral | 2 | 2020 | 3176 | 0.070 |
Why?
|
Apolipoproteins E | 1 | 2012 | 1438 | 0.070 |
Why?
|
Attention | 1 | 2017 | 2400 | 0.070 |
Why?
|
Respiratory Function Tests | 1 | 2011 | 1616 | 0.070 |
Why?
|
Oxidative Stress | 4 | 2020 | 3086 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2020 | 3557 | 0.070 |
Why?
|
Urban Population | 1 | 2015 | 2021 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 2 | 2021 | 2505 | 0.070 |
Why?
|
Reference Values | 2 | 2016 | 4982 | 0.070 |
Why?
|
Polymerase Chain Reaction | 2 | 2014 | 6171 | 0.070 |
Why?
|
Joint Instability | 1 | 2014 | 792 | 0.070 |
Why?
|
Fibrinolytic Agents | 2 | 2011 | 2158 | 0.070 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2007 | 75 | 0.070 |
Why?
|
Osteoarthritis | 1 | 2014 | 1036 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8642 | 0.070 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 627 | 0.070 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2016 | 6038 | 0.070 |
Why?
|
Chemokine CCL5 | 1 | 2006 | 209 | 0.070 |
Why?
|
Nutrition Policy | 1 | 2010 | 488 | 0.070 |
Why?
|
Cell Hypoxia | 1 | 2008 | 675 | 0.070 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2008 | 286 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2022 | 4262 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 2866 | 0.070 |
Why?
|
Lysine | 1 | 2010 | 1007 | 0.070 |
Why?
|
Clinical Trials, Phase II as Topic | 2 | 2023 | 629 | 0.060 |
Why?
|
Republic of Korea | 2 | 2019 | 539 | 0.060 |
Why?
|
Neoplasms, Second Primary | 1 | 2013 | 1061 | 0.060 |
Why?
|
Administration, Oral | 1 | 2013 | 3913 | 0.060 |
Why?
|
Spinal Cord | 1 | 2013 | 1809 | 0.060 |
Why?
|
Esophageal Neoplasms | 1 | 2015 | 1583 | 0.060 |
Why?
|
Epoxide Hydrolases | 1 | 2005 | 122 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 2734 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2014 | 2540 | 0.060 |
Why?
|
Cytokines | 2 | 2017 | 7322 | 0.060 |
Why?
|
Drug Evaluation | 1 | 2006 | 647 | 0.060 |
Why?
|
Birth Weight | 1 | 2013 | 2069 | 0.060 |
Why?
|
Multifactorial Inheritance | 2 | 2023 | 1194 | 0.060 |
Why?
|
Epidemiologic Factors | 1 | 2024 | 36 | 0.060 |
Why?
|
Breast Feeding | 1 | 2013 | 1338 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2016 | 2916 | 0.060 |
Why?
|
Prostate-Specific Antigen | 1 | 2014 | 2494 | 0.060 |
Why?
|
Rural Population | 1 | 2015 | 2210 | 0.060 |
Why?
|
Education, Graduate | 1 | 2005 | 81 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2016 | 3474 | 0.060 |
Why?
|
Blood Transfusion | 1 | 2010 | 1301 | 0.060 |
Why?
|
Transferrin | 1 | 2005 | 295 | 0.060 |
Why?
|
Leukocytes, Mononuclear | 3 | 2022 | 1836 | 0.060 |
Why?
|
Immunoenzyme Techniques | 3 | 2015 | 1799 | 0.060 |
Why?
|
Chemokine CCL2 | 1 | 2006 | 617 | 0.060 |
Why?
|
Gerbillinae | 1 | 2023 | 89 | 0.060 |
Why?
|
Hemochromatosis | 1 | 2005 | 184 | 0.060 |
Why?
|
Receptors, Transferrin | 1 | 2005 | 296 | 0.060 |
Why?
|
Vitamin B 6 | 2 | 2015 | 237 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2015 | 2899 | 0.060 |
Why?
|
Infant, Premature | 1 | 2013 | 2044 | 0.060 |
Why?
|
Physical Exertion | 1 | 2006 | 695 | 0.060 |
Why?
|
Kynurenine | 1 | 2023 | 139 | 0.060 |
Why?
|
Linkage Disequilibrium | 2 | 2019 | 1997 | 0.060 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 452 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2020 | 2948 | 0.060 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2013 | 3760 | 0.060 |
Why?
|
Japan | 2 | 2019 | 1360 | 0.050 |
Why?
|
Drug Industry | 1 | 2009 | 746 | 0.050 |
Why?
|
Dental Caries Susceptibility | 1 | 2022 | 25 | 0.050 |
Why?
|
Carcinoembryonic Antigen | 2 | 2001 | 349 | 0.050 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2005 | 401 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2018 | 3479 | 0.050 |
Why?
|
Nutrition Surveys | 2 | 2022 | 1660 | 0.050 |
Why?
|
Allelic Imbalance | 1 | 2002 | 77 | 0.050 |
Why?
|
Osteoporosis | 1 | 2012 | 1580 | 0.050 |
Why?
|
Bronchial Neoplasms | 1 | 2003 | 112 | 0.050 |
Why?
|
Central Nervous System Neoplasms | 1 | 2011 | 895 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 9274 | 0.050 |
Why?
|
Fatty Acids, Volatile | 1 | 2023 | 102 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2013 | 5391 | 0.050 |
Why?
|
Astrocytes | 2 | 2007 | 1270 | 0.050 |
Why?
|
Mesalamine | 1 | 2023 | 136 | 0.050 |
Why?
|
Child | 10 | 2023 | 77709 | 0.050 |
Why?
|
Chemokines | 1 | 2006 | 970 | 0.050 |
Why?
|
Electron Transport Complex IV | 1 | 2022 | 189 | 0.050 |
Why?
|
Furosemide | 1 | 2022 | 167 | 0.050 |
Why?
|
Hospitalization | 3 | 2020 | 10262 | 0.050 |
Why?
|
Antigens, CD20 | 1 | 2022 | 199 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2012 | 2050 | 0.050 |
Why?
|
Curriculum | 1 | 2015 | 3605 | 0.050 |
Why?
|
RNA Splicing | 1 | 2006 | 907 | 0.050 |
Why?
|
Cooperative Behavior | 1 | 2009 | 1504 | 0.050 |
Why?
|
Tryptophan | 1 | 2023 | 478 | 0.050 |
Why?
|
Patient Readmission | 1 | 2015 | 3114 | 0.050 |
Why?
|
Colon, Descending | 1 | 2021 | 8 | 0.050 |
Why?
|
Colon, Ascending | 1 | 2021 | 16 | 0.050 |
Why?
|
Graft vs Host Disease | 1 | 2014 | 2957 | 0.050 |
Why?
|
Infant | 2 | 2021 | 35136 | 0.050 |
Why?
|
Prebiotics | 1 | 2021 | 44 | 0.050 |
Why?
|
Colon, Transverse | 1 | 2021 | 23 | 0.050 |
Why?
|
Organoplatinum Compounds | 1 | 2022 | 408 | 0.050 |
Why?
|
Intention | 1 | 2024 | 341 | 0.050 |
Why?
|
Prevotella | 1 | 2021 | 79 | 0.050 |
Why?
|
Nucleic Acid Hybridization | 1 | 2002 | 1375 | 0.050 |
Why?
|
Immune System | 1 | 2006 | 805 | 0.050 |
Why?
|
Clinical Trials as Topic | 4 | 2021 | 7913 | 0.050 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 1378 | 0.050 |
Why?
|
Neurodegenerative Diseases | 1 | 2010 | 1061 | 0.050 |
Why?
|
Gene Expression Regulation | 3 | 2015 | 12072 | 0.050 |
Why?
|
Hematoxylin | 1 | 2020 | 64 | 0.050 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2020 | 72 | 0.050 |
Why?
|
Colon, Sigmoid | 1 | 2021 | 120 | 0.050 |
Why?
|
Endoscopy, Digestive System | 2 | 2009 | 345 | 0.050 |
Why?
|
Immunophenotyping | 2 | 2016 | 1880 | 0.050 |
Why?
|
Cecum | 1 | 2021 | 237 | 0.050 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2020 | 103 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 3923 | 0.050 |
Why?
|
Proctoscopy | 1 | 2020 | 42 | 0.050 |
Why?
|
Fructose | 1 | 2022 | 288 | 0.050 |
Why?
|
Bayes Theorem | 2 | 2020 | 2309 | 0.050 |
Why?
|
Antigens, CD19 | 1 | 2022 | 380 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3616 | 0.040 |
Why?
|
alpha-Fetoproteins | 1 | 2000 | 224 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2012 | 323 | 0.040 |
Why?
|
Cell Movement | 2 | 2016 | 5217 | 0.040 |
Why?
|
Survivors | 1 | 2010 | 2291 | 0.040 |
Why?
|
Germinoma | 1 | 2000 | 133 | 0.040 |
Why?
|
Bile Ducts, Extrahepatic | 1 | 2019 | 49 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2020 | 51 | 0.040 |
Why?
|
Poultry | 1 | 2019 | 82 | 0.040 |
Why?
|
Dietary Carbohydrates | 2 | 2018 | 906 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2017 | 11483 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2023 | 976 | 0.040 |
Why?
|
Killer Cells, Natural | 2 | 2021 | 2133 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 170 | 0.040 |
Why?
|
Cholecystectomy | 1 | 2021 | 395 | 0.040 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2019 | 111 | 0.040 |
Why?
|
Yogurt | 1 | 2019 | 72 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 8949 | 0.040 |
Why?
|
Ampulla of Vater | 1 | 2019 | 141 | 0.040 |
Why?
|
Neoplasm Seeding | 1 | 2019 | 87 | 0.040 |
Why?
|
Mammals | 1 | 2005 | 1143 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 2022 | 690 | 0.040 |
Why?
|
Lymphoid Tissue | 2 | 2014 | 455 | 0.040 |
Why?
|
Nitrosamines | 1 | 2019 | 87 | 0.040 |
Why?
|
Lipopolysaccharides | 1 | 2006 | 2216 | 0.040 |
Why?
|
Mortality | 2 | 2021 | 2864 | 0.040 |
Why?
|
Analgesics | 1 | 2006 | 1040 | 0.040 |
Why?
|
Bile Ducts | 1 | 2020 | 284 | 0.040 |
Why?
|
Israel | 1 | 2021 | 796 | 0.040 |
Why?
|
DNA Modification Methylases | 1 | 2019 | 206 | 0.040 |
Why?
|
Rectus Abdominis | 1 | 2019 | 97 | 0.040 |
Why?
|
Epidemiologic Methods | 2 | 2014 | 1364 | 0.040 |
Why?
|
Trans Fatty Acids | 1 | 2019 | 153 | 0.040 |
Why?
|
DNA | 1 | 2012 | 7301 | 0.040 |
Why?
|
Oxidants | 1 | 2019 | 164 | 0.040 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2019 | 226 | 0.040 |
Why?
|
Selenium | 1 | 2021 | 405 | 0.040 |
Why?
|
Methylation | 1 | 2021 | 1106 | 0.040 |
Why?
|
Career Mobility | 1 | 2020 | 262 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 1999 | 8863 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2022 | 783 | 0.040 |
Why?
|
Ketones | 1 | 2019 | 188 | 0.040 |
Why?
|
Pedigree | 2 | 2016 | 4644 | 0.040 |
Why?
|
Financial Management | 1 | 2019 | 160 | 0.040 |
Why?
|
Aspartate Aminotransferases | 1 | 2019 | 418 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2021 | 4420 | 0.040 |
Why?
|
Macrophage Activation | 1 | 2020 | 558 | 0.040 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 1999 | 339 | 0.040 |
Why?
|
Sex Characteristics | 2 | 2020 | 2585 | 0.040 |
Why?
|
DNA Repair Enzymes | 1 | 2019 | 349 | 0.040 |
Why?
|
Viremia | 1 | 2020 | 736 | 0.040 |
Why?
|
Probiotics | 1 | 2021 | 351 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 1157 | 0.040 |
Why?
|
Headache | 1 | 2005 | 1226 | 0.040 |
Why?
|
Glycemic Index | 1 | 2019 | 395 | 0.040 |
Why?
|
Transcription Factors | 2 | 2016 | 12208 | 0.040 |
Why?
|
Cell Count | 2 | 2015 | 1856 | 0.040 |
Why?
|
Hemoglobins | 1 | 2023 | 1534 | 0.040 |
Why?
|
Postoperative Complications | 1 | 1999 | 15295 | 0.040 |
Why?
|
Women's Health | 2 | 2019 | 2034 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2020 | 19229 | 0.040 |
Why?
|
ROC Curve | 2 | 2018 | 3527 | 0.040 |
Why?
|
Chromosome Mapping | 2 | 2016 | 4740 | 0.040 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2022 | 1240 | 0.040 |
Why?
|
Glycine Hydroxymethyltransferase | 1 | 2016 | 32 | 0.040 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2022 | 924 | 0.040 |
Why?
|
Platelet Count | 1 | 2019 | 781 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 954 | 0.030 |
Why?
|
Lymphatic Metastasis | 2 | 2016 | 2924 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1184 | 0.030 |
Why?
|
Social Justice | 1 | 2020 | 456 | 0.030 |
Why?
|
HIV-1 | 1 | 2014 | 6939 | 0.030 |
Why?
|
Independent Living | 1 | 2020 | 568 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2020 | 577 | 0.030 |
Why?
|
Siblings | 1 | 2020 | 854 | 0.030 |
Why?
|
Ribotyping | 1 | 2015 | 35 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2023 | 1676 | 0.030 |
Why?
|
Postprandial Period | 1 | 2017 | 292 | 0.030 |
Why?
|
Flavones | 1 | 2015 | 66 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2020 | 1100 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11727 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1655 | 0.030 |
Why?
|
Anthocyanins | 1 | 2015 | 79 | 0.030 |
Why?
|
Heparin | 1 | 2003 | 1637 | 0.030 |
Why?
|
Flavonols | 1 | 2015 | 83 | 0.030 |
Why?
|
Caco-2 Cells | 1 | 2016 | 387 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1142 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2020 | 1097 | 0.030 |
Why?
|
Pancreas | 1 | 2022 | 1686 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2016 | 408 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2003 | 2126 | 0.030 |
Why?
|
Food Handling | 1 | 2015 | 145 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2016 | 393 | 0.030 |
Why?
|
Cattle | 1 | 2021 | 3922 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3798 | 0.030 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2016 | 288 | 0.030 |
Why?
|
Communication | 1 | 2009 | 3749 | 0.030 |
Why?
|
Oral Health | 1 | 2020 | 472 | 0.030 |
Why?
|
Tumor Necrosis Factors | 1 | 2015 | 109 | 0.030 |
Why?
|
Physicians | 2 | 2011 | 4567 | 0.030 |
Why?
|
Riboflavin | 1 | 2015 | 108 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 711 | 0.030 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 2014 | 68 | 0.030 |
Why?
|
Antigens, CD | 2 | 2016 | 4026 | 0.030 |
Why?
|
DNA-Binding Proteins | 3 | 2019 | 9648 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1086 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 13881 | 0.030 |
Why?
|
Osteosarcoma | 1 | 2000 | 881 | 0.030 |
Why?
|
Florida | 1 | 2015 | 435 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2020 | 824 | 0.030 |
Why?
|
Drinking | 1 | 2015 | 197 | 0.030 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 1994 | 132 | 0.030 |
Why?
|
Minority Groups | 1 | 2022 | 1223 | 0.030 |
Why?
|
Hysterectomy | 1 | 2020 | 927 | 0.030 |
Why?
|
Fibrosis | 1 | 2021 | 2029 | 0.030 |
Why?
|
Chest Pain | 1 | 2021 | 1114 | 0.030 |
Why?
|
beta 2-Microglobulin | 1 | 1994 | 315 | 0.030 |
Why?
|
DNA Damage | 1 | 2024 | 2432 | 0.030 |
Why?
|
Joint Capsule | 1 | 2014 | 69 | 0.030 |
Why?
|
Nicotine | 1 | 2019 | 681 | 0.030 |
Why?
|
RNA Helicases | 1 | 2014 | 142 | 0.030 |
Why?
|
NF-kappa B | 1 | 2022 | 2499 | 0.030 |
Why?
|
Gastrostomy | 1 | 1996 | 309 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2014 | 2503 | 0.030 |
Why?
|
Radioimmunoassay | 1 | 2014 | 919 | 0.030 |
Why?
|
Regression Analysis | 2 | 2015 | 6459 | 0.030 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2015 | 373 | 0.030 |
Why?
|
Leisure Activities | 1 | 2015 | 311 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 1003 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2021 | 2699 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2020 | 1338 | 0.030 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2015 | 462 | 0.030 |
Why?
|
Genetic Techniques | 1 | 2016 | 435 | 0.030 |
Why?
|
Rats | 2 | 2007 | 24260 | 0.030 |
Why?
|
Lost to Follow-Up | 1 | 2013 | 105 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2012 | 0.030 |
Why?
|
Educational Status | 1 | 2021 | 2540 | 0.030 |
Why?
|
History, 21st Century | 1 | 2019 | 1534 | 0.030 |
Why?
|
Mice | 6 | 2021 | 81183 | 0.030 |
Why?
|
Mucous Membrane | 1 | 2016 | 673 | 0.030 |
Why?
|
Leucovorin | 1 | 2014 | 628 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2022 | 2046 | 0.030 |
Why?
|
Databases as Topic | 1 | 2015 | 475 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2013 | 25625 | 0.030 |
Why?
|
Computer Simulation | 2 | 2018 | 6196 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2013 | 426 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1411 | 0.030 |
Why?
|
Seizures | 1 | 2005 | 2859 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1855 | 0.030 |
Why?
|
RNA, Bacterial | 1 | 2014 | 390 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 315 | 0.030 |
Why?
|
Flow Cytometry | 3 | 2014 | 5974 | 0.030 |
Why?
|
Men | 1 | 2012 | 63 | 0.030 |
Why?
|
Sigmoid Neoplasms | 1 | 2012 | 51 | 0.030 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2018 | 806 | 0.030 |
Why?
|
Methionine | 1 | 2014 | 590 | 0.030 |
Why?
|
RNA, Viral | 1 | 2020 | 2902 | 0.030 |
Why?
|
Fasting | 1 | 2018 | 1593 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2020 | 2187 | 0.030 |
Why?
|
Pregnancy | 2 | 2022 | 29144 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2015 | 1107 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2016 | 2839 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2016 | 2256 | 0.030 |
Why?
|
Viral Load | 1 | 2020 | 3299 | 0.030 |
Why?
|
Environment | 1 | 2018 | 1124 | 0.030 |
Why?
|
Mouth | 1 | 2014 | 374 | 0.020 |
Why?
|
Quality of Life | 2 | 2023 | 12804 | 0.020 |
Why?
|
Telomerase | 1 | 2016 | 730 | 0.020 |
Why?
|
Camptothecin | 1 | 2014 | 576 | 0.020 |
Why?
|
Creatine | 1 | 2013 | 421 | 0.020 |
Why?
|
Endoscopy | 1 | 2021 | 1785 | 0.020 |
Why?
|
Patient Dropouts | 1 | 2013 | 421 | 0.020 |
Why?
|
Laminin | 1 | 2012 | 419 | 0.020 |
Why?
|
Macrophages | 2 | 2021 | 5655 | 0.020 |
Why?
|
Emotions | 1 | 2023 | 2661 | 0.020 |
Why?
|
Hypolipidemic Agents | 1 | 2015 | 604 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2013 | 576 | 0.020 |
Why?
|
Premenopause | 1 | 2015 | 1033 | 0.020 |
Why?
|
Pain | 1 | 2006 | 4986 | 0.020 |
Why?
|
Diuretics | 1 | 2014 | 592 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4560 | 0.020 |
Why?
|
Alcoholism | 1 | 2021 | 1906 | 0.020 |
Why?
|
Women | 1 | 2012 | 230 | 0.020 |
Why?
|
Interdisciplinary Studies | 1 | 2010 | 89 | 0.020 |
Why?
|
Phylogeny | 1 | 2018 | 2803 | 0.020 |
Why?
|
Receptors, Prostaglandin E, EP2 Subtype | 1 | 2010 | 40 | 0.020 |
Why?
|
Apoptosis | 1 | 2006 | 9727 | 0.020 |
Why?
|
Mice, Nude | 1 | 2017 | 3689 | 0.020 |
Why?
|
T-Box Domain Proteins | 1 | 2012 | 471 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2020 | 2416 | 0.020 |
Why?
|
Blotting, Southern | 2 | 2001 | 803 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2012 | 411 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4397 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2014 | 1369 | 0.020 |
Why?
|
Saliva | 1 | 2014 | 809 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1344 | 0.020 |
Why?
|
Viral Proteins | 1 | 2017 | 1900 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1157 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2014 | 783 | 0.020 |
Why?
|
Sample Size | 1 | 2012 | 845 | 0.020 |
Why?
|
Hospital Costs | 1 | 2015 | 985 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1708 | 0.020 |
Why?
|
Kinetics | 1 | 2017 | 6473 | 0.020 |
Why?
|
RNA Stability | 1 | 2011 | 321 | 0.020 |
Why?
|
Tumor Cells, Cultured | 3 | 2001 | 6314 | 0.020 |
Why?
|
Brain | 2 | 2023 | 26385 | 0.020 |
Why?
|
Morbidity | 1 | 2014 | 1769 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2014 | 1423 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3952 | 0.020 |
Why?
|
SEER Program | 1 | 2013 | 1508 | 0.020 |
Why?
|
Metaplasia | 1 | 2009 | 313 | 0.020 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2014 | 1122 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 2872 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7149 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2000 | 2529 | 0.020 |
Why?
|
Interleukin-2 | 1 | 1994 | 1904 | 0.020 |
Why?
|
Communicable Diseases | 1 | 2016 | 880 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 216 | 0.020 |
Why?
|
Anticoagulants | 1 | 2003 | 4599 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1889 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 16718 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 2014 | 1578 | 0.020 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2011 | 651 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 2013 | 975 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3920 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2017 | 16689 | 0.020 |
Why?
|
Papillomavirus Infections | 1 | 2018 | 1587 | 0.020 |
Why?
|
Bone Density Conservation Agents | 1 | 2014 | 773 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3022 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2007 | 528 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2007 | 537 | 0.020 |
Why?
|
Carcinoma, Small Cell | 1 | 2007 | 420 | 0.020 |
Why?
|
Binding Sites | 1 | 2014 | 6114 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2915 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2008 | 1588 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2015 | 1956 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4204 | 0.020 |
Why?
|
Venous Thromboembolism | 1 | 2017 | 1671 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 6365 | 0.020 |
Why?
|
Psoriasis | 1 | 2012 | 898 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5137 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 13815 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2015 | 3023 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2018 | 5172 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2006 | 1827 | 0.010 |
Why?
|
Orthopedic Procedures | 1 | 2014 | 1288 | 0.010 |
Why?
|
Cornified Envelope Proline-Rich Proteins | 1 | 2003 | 10 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2015 | 2838 | 0.010 |
Why?
|
Medicare | 1 | 2021 | 6566 | 0.010 |
Why?
|
Ultrasonography | 1 | 1996 | 5985 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2716 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2007 | 644 | 0.010 |
Why?
|
Interferon-alpha | 1 | 2007 | 895 | 0.010 |
Why?
|
Partial Thromboplastin Time | 1 | 2003 | 206 | 0.010 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2007 | 1475 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2022 | 35421 | 0.010 |
Why?
|
Central Nervous System | 1 | 2008 | 1357 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2007 | 2726 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5853 | 0.010 |
Why?
|
Osteonectin | 1 | 2000 | 34 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2012 | 3462 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2002 | 684 | 0.010 |
Why?
|
Musculoskeletal Diseases | 1 | 2006 | 581 | 0.010 |
Why?
|
Intestines | 1 | 2009 | 1924 | 0.010 |
Why?
|
Osteocalcin | 1 | 2000 | 273 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2014 | 21827 | 0.010 |
Why?
|
Phosphorylation | 1 | 2010 | 8436 | 0.010 |
Why?
|
Sialoglycoproteins | 1 | 2000 | 318 | 0.010 |
Why?
|
Mental Disorders | 1 | 2019 | 6600 | 0.010 |
Why?
|
Drug Costs | 1 | 2006 | 1105 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2003 | 2274 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2008 | 4803 | 0.010 |
Why?
|
Drug Monitoring | 1 | 2003 | 956 | 0.010 |
Why?
|
DNA Primers | 1 | 2001 | 2892 | 0.010 |
Why?
|
Pain Measurement | 1 | 2006 | 3420 | 0.010 |
Why?
|
Blotting, Western | 1 | 2003 | 5179 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1994 | 329 | 0.010 |
Why?
|
Warfarin | 1 | 2003 | 1496 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1996 | 20129 | 0.010 |
Why?
|
Cyclosporine | 1 | 1994 | 786 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2007 | 4034 | 0.010 |
Why?
|
Collagen | 1 | 2000 | 2689 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18029 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1994 | 1866 | 0.010 |
Why?
|
Spleen | 1 | 1994 | 2362 | 0.010 |
Why?
|
Pilot Projects | 1 | 2000 | 8324 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 2000 | 7722 | 0.000 |
Why?
|